Alterity Therapeutics Files Director Interest Notice
Ticker: PRNAF · Form: 6-K · Filed: Sep 20, 2024 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Sep 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-filing, registration-statement, disclosure
Related Tickers: ATHE
TL;DR
ALTERITY THERAPEUTICS LTD (ATHE) filed a 6-K for director interest changes, incorporated into S-8/F-3 filings.
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on September 20, 2024, to report a Change of Director's Interest Notice. This filing is being incorporated by reference into several of the company's existing Registration Statements on Form S-8 and Form F-3.
Why It Matters
Changes in director interests can signal shifts in insider confidence or strategic adjustments within the company.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of director interest changes and does not indicate significant new risks.
Key Players & Entities
- Alterity Therapeutics Limited (company) — Registrant
- September 20, 2024 (date) — Filing date
- Form 6-K (document) — Filing type
- Form S-8 (document) — Incorporated filing
- Form F-3 (document) — Incorporated filing
FAQ
What specific change in director's interest is reported in the 6-K filing?
The filing indicates a 'Change of Director's Interest Notice' was submitted, but the specific details of the change are not provided in the summary text.
Which registration statements is this 6-K filing being incorporated into?
This Form 6-K is being incorporated by reference into Alterity Therapeutics' Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, and 333-250076).
What is the principal executive office address of Alterity Therapeutics Limited?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
What is the SIC code for Alterity Therapeutics Ltd?
The Standard Industrial Classification (SIC) code for Alterity Therapeutics Ltd is 2834, which corresponds to Pharmaceutical Preparations.
What is the former name of Alterity Therapeutics Limited?
The former name of Alterity Therapeutics Limited was PRANA BIOTECHNOLOGY LTD, with a date of name change on January 5, 2001.
Filing Stats: 191 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2024-09-20 08:00:17
Filing Documents
- ea0215217-6k_alterity.htm (6-K) — 13KB
- ea021521701ex99-1_alterity.htm (EX-99.1) — 63KB
- 0001213900-24-080422.txt ( ) — 77KB
From the Filing
OF FOREIGN PRIVATE ISSUER SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-163 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Alterity Therapeutics Limited (Name of Registrant) Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073 , 333-248980 and 333-228671 ) and our Registration Statements on Form F-3 (Files No. 333-274816 , 333-251647 , 333-231417 and 333-250076 ) ALTERITY THERAPEUTICS LIMITED (a development stage enterprise) The following exhibits are submitted: 99.1 Change of Director's Interest Notice x 2 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alterity Therapeutics Limited By: /s/ Geoffrey P. Kempler Geoffrey P. Kempler Chairman Date: September 20, 2024 2